semaglutide vs. tirzepatide for weight loss vs Tirzepatide vs Semaglutide: Key Differences
Description
Tesamorelin does not hold a marketing authorisation in the United Kingdom and is not available via routine NHS prescribing or as a BNF-listed product
Ozempic, a Type 2 diabetes medication, and its sister drug Wegovy, which is specifically approved for weight loss, both contain semaglutide, which mimics GLP-1
Tirzepatide has a plasma half-life of approximately 5 days (120 hours), supporting once-weekly subcutaneous dosing
Semaglutide is primarily used to treat type 2 diabetes and obesity, but it also offers benefits for other related conditions: Semaglutide is FDA-approved for the treatment of type 2 diabetes
The good news is that hair loss related to weight loss is usually manageable
